This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignees: Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 2016.
Company Filing History:
1 out of 8,578 
1 out of 3,071 
Years Active: 2016
Title: The Innovative Contributions of Daniel Fass
Introduction
Daniel Fass is an accomplished inventor based in Winchester, MA (US). He has made significant strides in the field of neuroscience, particularly in the treatment of bipolar disorder and other brain disorders. His innovative approach involves the use of chemical compounds to modulate GSK-3 signaling, which has the potential to transform therapeutic strategies for neurological and psychiatric conditions.
Latest Patents
Daniel Fass holds a patent for the "Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders." This patent encompasses various aspects related to the use of chemical compounds that can inhibit GSK-3 and stabilize β-catenin. The invention also includes formulations and compositions comprising these compounds. Furthermore, it provides methods for using these compounds and compositions in treating subjects with neurological diseases and psychiatric disorders. Notably, some embodiments involve administering these compounds in combination with Lithium.
Career Highlights
Throughout his career, Daniel Fass has worked with prestigious organizations, including The General Hospital Corporation and the Massachusetts Institute of Technology. His experience in these institutions has contributed to his expertise in the field of neuroscience and innovation.
Collaborations
Daniel has collaborated with notable colleagues, including Josh Ketterman and Jennifer Q Pan. These collaborations have likely enriched his research and development efforts in the realm of brain disorders.
Conclusion
Daniel Fass is a pioneering inventor whose work in modulating GSK-3 signaling represents a significant advancement in the treatment of bipolar disorder and other neurological conditions. His contributions to the field are invaluable and continue to inspire further research and innovation.